viernes, 9 de junio de 2017

Ivanhoe's Top 5 Reports This Week

Marketing

PORTLAND, Ore. (Ivanhoe Newswire) – It’s only the size of a pea, but the pituitary gland is so important it’s often called the body’s master gland. So when it doesn’t work right, big problems, literally and figuratively, arise. Here are the details on the latest research about often overlooked disorders.



COLUMBUS, Ohio. (Ivanhoe Newswire) – The FDA has approved a new drug to treat people living with multiple sclerosis, a chronic auto-immune disorder that causes a patient’s own system to attack his or her brain and spinal cord. The drug is not a cure, but the treatment will allow some patients to live virtually symptom-free for the first time in years.



DALLAS. (Ivanhoe Newswire) – Hair loss is mistakenly thought of as a male disease, but 40 percent of women have visible hair loss by the time they reach age 40. The psychological damage can be devastating. Wigs and hair pieces offer some help, but now a new hair system from Italy is making a huge difference for some women.



MIAMI. (Ivanhoe Newswire) — You’ve heard it countless times: it runs in the family. But usually people are talking about the color of your hair or problems with your heart. However, a dental decay gene may also be something your parents have passed along to you.



MIAMI. (Ivanhoe Newswire) — Imagine waking up one day unable to speak. It’s a devastating disorder. See how music is helping those suffering the loss of language.

Summer Camps at ClearOne
Orlando, Florida!  Kids 6 to 18 
Pickleball, Badminton and Ping Pong
Call 407 730 3596 or
email:  orlando@clearonebadminton.com
to reserve a spot!



Smart Living for this week:

Distracted Driving: Garrett’s Story

Dressing Curvy Women

Big Cat Rescue

A New Cure for Burnout




Doctor's In-depth Interview of the week

 



Quote of the week:

I am troubled by my shapeless fears. My God, these anxieties! Who can live in the modern world without catching his share of them?” 

— Vincent van Gogh


Website Information: webdoctor@ivanhoe.com

Content Licensing: jcherry@ivanhoe.com

No hay comentarios:

Publicar un comentario